- Community-Beiträge
- Aktuellste Threads
| Aktientyp | Stammaktie |
Was kann man hier aus Aktien raus bekommen?
Gibt's hier was zu spielen?
http://www.samaritanpharma.com/news_pr.asp
Samaritan Pharmaceuticals, Inc. (AMEX:LIV - News) is pleased to announce that its subsidiary Samaritan Pharmaceuticals Europe, S.A. has received notification, from the Cyprus Ministry of Health, that its marketing authorization for HIV fungus drug Amphocil has been approved in Cyprus. The Cyprus Ministry of Health is the competent authority to grant approvals to market pharmaceutical drugs in Cyprus, similar to the FDA in the United States.
Eugene Boyle, CFO of Samaritan Pharmaceuticals stated, “We anticipate starting sales of Amphocil in Cyprus shortly after we establish an official price with the Minister of Health. It is exciting to see Samaritan’s business strategy, to sell approved specialty drugs in Greece and Eastern Europe, expanding and growing revenue opportunities.”
